Description of Velpanat - 12 weeks
Velpanat is a combination of two prime anti-viral medications which is used for the treatment of chronic hepatitis C virus infection
Drug Name: Velpatasvir and Sofosbuvir
Strength of the drug: Velpatasvir 100mg and Sofosbuvir 400mg
Manufactured by : Natco Pharma Limited
Container : 28 tablets
Velpanat (Sofosbuvir and Velpatasvir): This helps to anticipate hepatitis C virus (HCV) from replication.
SOFOSBUVIR VELPATASVIR indication:
Velpanat is a brand, usually it is a prescription medicine used only for adult patient who are suffered with chronic (lasting a long time) hepatitis C genotype I, II, III, IV, V or VI infection with or without cirrhosis (compensated).
Patient with advanced cirrhosis (decompensated), in this condition Velpanat is combined with ribavirin.
Pharmacology of Velpanat - 12 weeks
Indication of Velpanat - 12 weeks
Dose & Dosage's of Velpanat - 12 weeks
Velpanat is administered with or without food.
Side Effects of Velpanat - 12 weeks
Desirable side effects:
In advanced cirrhosis, patient taking Velpanat with ribavirin in the condition they attain some common side effects includes anemia, nausea, insomnia, and diarrhea.
Contraindication of Velpanat - 12 weeks
Drug Interaction of Velpanat - 12 weeks
Precaution of Velpanat - 12 weeks
Usage & Safety profile of Velpanat - 12 weeks Pregnancy & Lactation
Storage of Velpanat - 12 weeks
Store at below 30 °C (86 °F).
Medicine will dispense only in original container.